The Texas Heart Institute (THI) is advertising for trial participants through a range of social media platforms ..... interesting that one of the trials listed is using BM derived MSC's - let's hope that they put a huge effort into either the additional phase 3 or the phase 4 confirmatory trial for Mesoblast's Rexlemestrocel when it finally gets underway ?
One would think that the THI must believe there is some merit in using stem cells in relation to treating heart failure ..... GLTAH
"The Texas Heart Institute is currently enrolling subjects for several heart failure-related studies."
https://clinicaltrials.gov/study/NCT02962661?term=NCT02962661&rank=1#contacts-and-locations
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
https://www.texasheart.org/research...dard-of-care-in-cardiomyopathy-mdacc-thi-msc/
Stem Cell Therapy vs Standard of Care in Cardiomyopathy (NCT02962661)
Cell Therapy News/Articles, page-17478
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
0.035(2.89%) |
Mkt cap ! $1.421B | |||
| Open | High | Low | Value | Volume |
| $1.21 | $1.25 | $1.18 | $4.096M | 3.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22000 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 36989 | 4 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |